JVSCX
Price
$15.39
Change
+$0.07 (+0.46%)
Updated
Jul 13 closing price
Net Assets
71.67M
VMVAX
Price
$104.78
Change
+$0.48 (+0.46%)
Updated
Jul 13 closing price
Net Assets
37.23B
Interact to see
Advertisement

JVSCX vs VMVAX

JVSCX vs VMVAX Comparison Chart in %
View a ticker or compare two or three
VS
JVSCX vs. VMVAX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVSCX is a Hold and VMVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 37.2B vs. JVSCX (71.7M). VMVAX pays higher dividends than JVSCX: VMVAX (1.88) vs JVSCX (0.00). JVSCX was incepted earlier than VMVAX: JVSCX (15 years) vs VMVAX (15 years). JVSCX (2.79) is less costly to investors than VMVAX (0.07). JVSCX is a more actively managed with annual turnover of: 76.00 vs. VMVAX (23.00). JVSCX has a lower initial minimum investment than VMVAX: JVSCX (2500) vs VMVAX (3000). VMVAX annual gain was more profitable for investors over the last year : 20.58 vs. JVSCX (5.12). VMVAX return over 5 years is better than : 46.00 vs. JVSCX (16.50).
JVSCXVMVAXJVSCX / VMVAX
Total Expense Ratio2.010.072,871%
Annual Report Gross Expense Ratio2.790.073,986%
Fund Existence15 years15 years-
Gain YTD10.40213.61576%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets71.7M37.2B0%
Annual Yield % from dividends0.001.88-
Returns for 1 year5.1220.5825%
Returns for 3 years18.6643.5643%
Returns for 5 years16.5046.0036%
Returns for 10 years26.99123.4122%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GAGIX37.84N/A
N/A
Gabelli Global Rising Income and Div I
GKIRX28.54N/A
N/A
Goldman Sachs Income Builder Inv
MKSPX38.39N/A
N/A
BlackRock Advantage SMID Cap K
GCPYX23.71-0.10
-0.42%
Gateway Equity Call Premium Y
BPTIX281.09-2.88
-1.01%
Baron Partners Institutional